Alkermes shares slump after watchdog blow to drug trial - Independent.ie
Alkermes CEO nets $3.5M in stock sales since April - Boston Business Journal
17. Richard Pops, Alkermes | FiercePharma
Richard Pops, chief executive officer of Alkermes Plc, listens during... News Photo - Getty Images
Moving From Crisis To Lasting Change
6 Things You Might Not Know About Richard Pops CEO Of Alkermes
Alkermes executives take a hit on pay package
Life Science Leader May 2019
Richard Pops - CEO @ Alkermes - Crunchbase Person Profile
Alkermes looks to schizophrenia drug approval as sales jump 24%
Alkermes prefers independence and opts out of takeover trend
Richard Pops CEO Alkermes Interview | newscentermaine.com
Alkermes Inspiration Grants® | Alkermes
Richard "Pops" Smith Kidney Campaign - Home | Facebook
Alkermes loss rises to $77m in first quarter
Irish drug firm Alkermes sees revenues rise 15% in Q4
Alkermes Has Launched Employee Resource Groups | News Direct
Richard Pops (@popsalks) / Twitter
PDF) Alkermes And Richard Pops -The Evolution Of A Company And Its Leader
Alkermes's key strength is potent pharma pipeline
Blood-Brain Barrier Booming As A Source Of New Biotechnology Research Challenges | The Scientist Magazine®
Richard Pops
Alkermes stock climbs on positive test results for antidepressant - The Boston Globe
